MITF reprograms the extracellular matrix and focal adhesion in melanoma is a research paper published in eLife (2021). On theSindex it has a DataRank of 2.0. It has been cited 87 times, with 62 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.672
From this paper's citation signal
Citation Network Contribution
1.3
From 51 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 62 citers.
Icelandic Centre for Research
Grant: 184861
National Institutes of Health
Grant: A2062457
H2020 European Research Council
Grant: ZF-MEL-CHEMBIO-648489
L'Oreal Melanoma Research Alliance
Grant: 401181
MRC
Grant: MC_UU_00007/9
Gene-drug interactions in the melanocyte lineage and melanoma
University of Iceland
Grant: Doctoral grant fund - HI16120042
Icelandic Centre for Research
Grant: 767-207067
Anna-Maria and Stephen Kellen Foundation-Melanoma Research Alliance Team Science Award
Grant: #687306
NIAMS NIH HHS
Grant: R01 AR062547
European Research Council
Grant: 648489
Chemical Biology in Zebrafish: Drug-Leads and New Targets in the Melanocyte Lineage and Melanoma
FWCI
7.06
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
Additional file 1 of SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma